The Neurosciences Journal includes this section of multiple choice questions as part of its commitment to continuous education and learning in Neurosciences. Experts in various neuroscience specialties are invited to participate with their knowledge and expertise in this section.

Neurology, neurosurgery, and other board residents are encouraged to read this section to improve their knowledge and direct their reading for written examinations.

**Choose the most appropriate single answer.**

A full term neonate developed progressive, intractable seizures in the first day of life. Clinically, he is encephalopathic and laying in opisthotonic posture. Antenatal and perinatal history were unremarkable. Cord blood gas was normal. MRI imaging is obtained (**Figure 1**).

The history and imaging is most likely suggestive of the following:Hypoxic ischemic insultSulfite oxidase deficiencyNonketotic hyperglycinemiaPyridoxine dependent epilepsyCortical dysplasiaHow would you differentiate between sulfite oxidase deficiency and molybdenum cofactor deficiency?Urinary xanthine and hypoxanthine levels are elevated in molybdenum cofactor deficiency but are normal in those with sulfite oxidase deficiencyUric acid is elevated in sulfite oxidase deficiencyUrinary thiosulfate level is low in sulfite oxidase deficiencyHomocysteine level is usually high in sulfite oxidase deficiencyNone of the aboveWhat is the mood of inheritance of sulfite oxidase deficiency?Autosomal dominantAutosomal recessiveX-linked dominantX-linked recessiveSporadicSulfite oxidase deficiency is encoded by which of the following genes?MOCS1 geneMOCS2 geneSUOX geneGEPH geneNone of the aboveWhich of the following is an effective treatment in sulfite oxidase deficiency?Vitamin B6ThiamineBiotinL carnitineNone of the above

**Answers:**

**b**Sulfite oxidase deficiency is an inborn error of the metabolism of sulfated amino acids, which causes accumulation of sulphite in biologic fluids and tissues. Affected individuals commonly present in the neonatal period with intractable seizures, abnormal tone, and feeding difficulties. Pregnancy and delivery history are typically normal. Magnetic resonance imaging shows diffuse cystic lesions within the white matter, basal ganglia and thalamus along with ulegyric changes in the cerebral cortex and cerebellar hypoplasia.[@ref1]**a**Both sulfite oxidase deficiency and molybdenum cofactor deficiency have virtually identical phenotypes. An elevated urinary thiosulfate level is essentially diagnostic of sulfite oxidase deficiency or molybdenum cofactor deficiency. The plasma uric acid level is typically low or low-normal in individuals with molybdenum cofactor deficiency; however, it is normal in those with isolated sulfite oxidase deficiency. Urinary xanthine and hypoxanthine levels are elevated in individuals with molybdenum cofactor deficiency, but are normal in those with sulfite oxidase deficiency. Confirmation of the disease requires enzymatic and genetic studies.[@ref2]**b**Sulfite oxidase deficiency is an autosomal recessive disorder, meaning that the parents are carriers of the mutation in this gene even though they do not suffer from the effects of this enzymatic deficiency. If both parents transmit a mutation to their offspring, the child will suffer from the disease.[@ref3]**c**Sulfite oxidase deficiency is caused by a mutation in the SUOX gene (12q13.13), which encodes the enzyme sulfite oxidase that catalyzes sulfite to sulfate, a process essential for the catabolism of sulfur-containing amino acids. MOCS1, MOCS2, or GPHN gene mutations causes molybdenum cofactor deficiency.[@ref4]**E**There is no cure for sulfite oxidase deficiency and prognosis is usually poor. Antiepileptic drugs in various combinations are used for control of seizures. Administration of diets low in sulfur containing amino acids along with sulfate supplementation have been attempted with positive biochemical response but with no lasting neurological improvement.[@ref5]
